British medical bulletin · 2021
Platelet-rich plasma versus steroids injections for greater trochanter pain syndrome: a systematic review and meta-analysis.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Migliorini Filippo, Kader Nardeen, Eschweiler Jörg, Tingart Markus, Maffulli Nicola
Аннотация
INTRODUCTION: Greater trochanter pain syndrome (GTPS) is characterized by a persistent and debilitating pain around the greater trochanter. GTPS can be caused by a combination of gluteus medius or minimus tendinopathy, snapping hip or trochanteric bursitis.
SOURCE OF DATA: Recent published literatures identified from PubMed, EMBASE, Google Scholar, Scopus.
AREAS OF AGREEMENT: Platelet rich plasma (PRP) and corticosteroids (CCS) injections are useful options to manage symptoms of GTPS.
AREAS OF CONTROVERSY: Whether PRP leads to superior outcomes compared to CCS injections is unclear.
GROWING POINTS: A systematic review and meta-analysis comparing PRP versus CCS in the management of GTPS was conducted.
AREAS TIMELY FOR DEVELOPING RESEARCH: PRP injections are more effective than CCS at approximately 2 years follow-up.
SOURCE OF DATA: Recent published literatures identified from PubMed, EMBASE, Google Scholar, Scopus.
AREAS OF AGREEMENT: Platelet rich plasma (PRP) and corticosteroids (CCS) injections are useful options to manage symptoms of GTPS.
AREAS OF CONTROVERSY: Whether PRP leads to superior outcomes compared to CCS injections is unclear.
GROWING POINTS: A systematic review and meta-analysis comparing PRP versus CCS in the management of GTPS was conducted.
AREAS TIMELY FOR DEVELOPING RESEARCH: PRP injections are more effective than CCS at approximately 2 years follow-up.